Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia

European Journal of Haematology

Volumn 72, Issue 6, 2004, Pages 455-456

  Zver, Samo ^a   Andoljšek, Dušan ^a   Černelč, Peter ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

IDARUBICIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RETINOIC ACID; TRANEXAMIC ACID;

ABDOMINAL RADIOGRAPHY; ADULT; BLEEDING; CANCER PATIENT; CASE REPORT; DOSE RESPONSE; DRUG EFFICACY; ECHOGRAPHY; FEMALE; HUMAN; LABORATORY TEST; LETTER; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

ADULT; BLOOD TRANSFUSION; CATHETERIZATION, CENTRAL VENOUS; CRITICAL ILLNESS; FACTOR VII; FEMALE; FEMORAL ARTERY; HEMORRHAGE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; RECOMBINANT PROTEINS; TRETINOIN;

EID: 2542524560     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2004.00237.x     Document Type: Letter

References (3)

1. AVVISATI G, PETTI M, COCO FL, et al. Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: Final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow up. Blood 2002;100:3141-3146.
2. MARTINOWITZ U, KENET G, SEGAL E, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001;51:431-439.
3. MOSCARDO F, PEREZ F, DE LA RUBIA J, BALERDI B, LORENZO JI. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 2001; 113:174-176.